^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PF-06688992

    i
    Other names: PF-06688992, PF 06688992, GD3 ADC
    Associations
    News
    Trials
    Company:
    Pfizer
    Drug class:
    GD3-targeted antibody-drug conjugate
    Associations
    News
    Trials